Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans

Fig. 3

Endotoxin reduces the quantity of apo A-containing particles. The concentration of plasma (a) apoA-I and apoA-I containing lipoprotein subclass, (b) LpA-I, (c) LpA-I:A-II were measured in subjects at baseline and for 8 h after an intravenous dose of endotoxin (closed circles, n = 12) or saline (open circles, n = 4) groups. Data were analyzed by 2-way repeated measures ANOVA (time x LPS)

Back to article page